Influence of endothelial cell protein C receptor on breast cancer development

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 11, 2013, Pages 2062-2065

  Keshava, S ^a   Kothari, H ^a   Rao, L V M ^a   Pendurthi, U R ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ENDOTHELIAL PROTEIN C RECEPTOR; PHLEOMYCIN; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; ACTIVATED PROTEIN C RECEPTOR; BLOOD CLOTTING FACTOR; CELL SURFACE RECEPTOR; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST CANCER; CANCER GROWTH; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRIN FORMATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR SIGNALING; LETTER; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TUMOR VOLUME; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; DISEASE COURSE; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BLOOD COAGULATION FACTORS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PLATELET ACTIVATION; PROTEIN C; RECEPTORS, CELL SURFACE; THROMBIN;

EID: 84887517255     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12402     Document Type: Letter

References (10)

1. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007; 109: 3161-72.
2. Rezaie AR. Regulation of the protein C anticoagulant and antiinflammatory pathways. Curr Med Chem 2010; 17: 2059-69.
3. Beaulieu LM, Church FC. Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1. Exp Cell Res 2007; 313: 677-87.
4. Anton I, Molina E, Luis-Ravelo D, Zandueta C, Valencia K, Ormazabal C, Martinez-Canarias S, Perurena N, Pajares MJ, Agorreta J, Montuenga LM, Segura V, Wistuba II, De Las RJ, Hermida J, Lecanda F. Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med 2012; 186: 96-105.
5. Keshava S, Sahoo S, Tucker TA, Idell S, Rao LV, Pendurthi UR. Endothelial cell protein C receptor opposes mesothelioma growth driven by tissue factor. Cancer Res 2013; 73: 3963-73.
6. Schaffner F, Yokota N, Carneiro-Lobo T, Kitano M, Schaffer M, Anderson GM, Mueller BM, Esmon CT, Ruf W. Endothelial protein C receptor function in murine and human breast cancer development. PLoS ONE 2013; 8: e61071.
7. Richards CH, Mohammed Z, Qayyum T, Horgan PG, McMillan DC. The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncol 2011; 7: 1223-35.
8. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999; 79: 991-5.
9. Woolf N. Cell, Tissue and Disease: The Basis of Pathology. London: Bailliere Tindall, 1986: 25-30.
10. Liao D, Johnson RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007; 26: 281-90.